首页> 外文期刊>Life sciences >Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment
【24h】

Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment

机译:人的脐带间充质干细胞衍生 - 疾病治疗中的外泌体

获取原文
获取原文并翻译 | 示例
       

摘要

Exosomes are extracellular vesicles with the size of 40-100 nm in diameter and a density of 1.13-1.19 g/mL, containing proteins, mRNAs, miRNAs, and DNAs. Exosomes change the recipient cells biochemical features through biomolecules delivery and play a role in cellular communication. These vesicles are produced from body fluids and different cell types like mesenchymal stem cells (MSCs). Evidence suggests that mesenchymal stem cells-derived exosome (MSC-EXO) exhibit functions similar to MSCs with low immunogenicity and no tumorization. MSCs can also be isolated from a variety of sources including human umbilical cord (HUC). Because of the non-invasive collection method, higher proliferation and lower immunogenicity, HUCMSC-EXO has been frequently used in regenerative medicine and various diseases treatment compared to the other MSC-EXO resources. This review aimed to investigate the applications of HUCMSC-EXO in different diseases.
机译:外泌体是尺寸为40-100nm的细胞外囊,密度为1.13-1.19g / ml,含有蛋白质,mRNA,miRNA和DNA。 外泌体通过生物分子递送改变受体细胞生物化学特征,并在蜂窝通信中发挥作用。 这些囊泡由体液和不同的细胞类型(如间充质干细胞(MSC)产生。 证据表明,间充质干细胞衍生的外渗(MSC-EXO)表现出类似于具有低免疫原性和肿瘤的MSC的功能。 MSC也可以从包括人脐带(HUC)的各种来源隔离。 由于非侵入性收集方法,较高的增殖和降低免疫原性,Hucmsc-EXO经常用于再生医学和各种疾病治疗,与其他MSC-EXO资源相比。 该审查旨在调查Hucmsc-EXO在不同疾病中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号